| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Future treatments for Sjögren's syndrome
|
Pers, Jacques-Olivier
|
|
2016
|
45 |
6P2 |
p. e193-e200
nvt p.
|
artikel
|
| 2 |
Innovations in autoimmune diseases
|
Guillevin, Loïc
|
|
2016
|
45 |
6P2 |
p. e157-e158
nvt p.
|
artikel
|
| 3 |
New therapeutic approaches for ANCA-associated vasculitides
|
Chaigne, Benjamin
|
|
2016
|
45 |
6P2 |
p. e171-e178
nvt p.
|
artikel
|
| 4 |
New therapeutic approaches in rheumatoid arthritis
|
van Vollenhoven, Ronald F.
|
|
2016
|
45 |
6P2 |
p. e179-e192
nvt p.
|
artikel
|
| 5 |
Stem cell transplantation and mesenchymal cells to treat autoimmune diseases
|
Tyndall, Alan
|
|
2016
|
45 |
6P2 |
p. e159-e169
nvt p.
|
artikel
|
| 6 |
Therapeutic innovations in endocrine diseases – Part 2: Modified-release glucocorticoid compounds: What good do they provide to the adrenal insufficient patient?
|
Reznik, Yves
|
|
2016
|
45 |
6P2 |
p. e205-e210
nvt p.
|
artikel
|
| 7 |
Therapeutic innovations in endocrine diseases – Part 1: New medical treatments for chronic excess of endogenous cortisol (Cushing's syndrome)
|
Bertagna, Xavier
|
|
2016
|
45 |
6P2 |
p. e201-e204
nvt p.
|
artikel
|
| 8 |
Therapeutic innovations in endocrine diseases – Part 4 : Pasireotide: Long-acting release somatostatin analogue
|
Wémeau, Jean-Louis
|
|
2016
|
45 |
6P2 |
p. e217-e220
nvt p.
|
artikel
|
| 9 |
Therapeutic innovations in endocrine diseases – Part 5: Rituximab and graves’ orbitopathy
|
Ladsous, Miriam
|
|
2016
|
45 |
6P2 |
p. e221-e224
nvt p.
|
artikel
|
| 10 |
Therapeutic innovations in endocrine diseases – part 3 : temozolomide and future therapeutics for aggressive pituitary tumors and carcinomas
|
Lasolle, Hélène
|
|
2016
|
45 |
6P2 |
p. e211-e216
nvt p.
|
artikel
|
Tijdschrift beschrijving